<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>Patient Summary Dashboard - DOE, JOHN</title>
<style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            padding: 20px;
            color: #333;
        }
        
        .container {
            max-width: 1400px;
            margin: 0 auto;
            background: white;
            border-radius: 10px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.2);
            overflow: hidden;
        }
        
        .header {
            background: linear-gradient(135deg, #4a5568 0%, #2d3748 100%);
            color: white;
            padding: 30px;
            text-align: center;
        }
        
        .header h1 {
            font-size: 32px;
            margin-bottom: 10px;
        }
        
        .header p {
            font-size: 14px;
            opacity: 0.9;
        }
        
        .patient-info {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 20px;
            padding: 30px;
            background: #f7fafc;
            border-bottom: 3px solid #e2e8f0;
        }
        
        .info-card {
            background: white;
            padding: 20px;
            border-radius: 8px;
            box-shadow: 0 2px 8px rgba(0,0,0,0.1);
            border-left: 4px solid #4299e1;
        }
        
        .info-card h3 {
            color: #2d3748;
            font-size: 14px;
            text-transform: uppercase;
            letter-spacing: 1px;
            margin-bottom: 10px;
        }
        
        .info-card p {
            font-size: 18px;
            font-weight: 600;
            color: #4a5568;
        }
        
        .content {
            padding: 30px;
        }
        
        .section {
            margin-bottom: 40px;
        }
        
        .section h2 {
            color: #2d3748;
            font-size: 24px;
            margin-bottom: 20px;
            padding-bottom: 10px;
            border-bottom: 2px solid #e2e8f0;
        }
        
        .diagnosis-list {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 15px;
        }
        
        .diagnosis-item {
            background: #fff5f5;
            border-left: 4px solid #f56565;
            padding: 15px;
            border-radius: 5px;
        }
        
        .diagnosis-item.chronic {
            background: #fffaf0;
            border-left-color: #ed8936;
        }
        
        .diagnosis-item h4 {
            color: #2d3748;
            margin-bottom: 8px;
        }
        
        .diagnosis-item p {
            font-size: 14px;
            color: #718096;
            margin-bottom: 4px;
        }
        
        .timeline {
            position: relative;
            padding-left: 40px;
        }
        
        .timeline::before {
            content: '';
            position: absolute;
            left: 10px;
            top: 0;
            bottom: 0;
            width: 2px;
            background: #cbd5e0;
        }
        
        .timeline-item {
            position: relative;
            margin-bottom: 30px;
            padding-left: 20px;
        }
        
        .timeline-item::before {
            content: '';
            position: absolute;
            left: -34px;
            top: 5px;
            width: 12px;
            height: 12px;
            border-radius: 50%;
            background: #4299e1;
            border: 3px solid white;
            box-shadow: 0 0 0 2px #4299e1;
        }
        
        .timeline-item.critical::before {
            background: #f56565;
            box-shadow: 0 0 0 2px #f56565;
        }
        
        .timeline-date {
            font-weight: 600;
            color: #4299e1;
            margin-bottom: 5px;
        }
        
        .timeline-content {
            background: #f7fafc;
            padding: 15px;
            border-radius: 5px;
            border: 1px solid #e2e8f0;
        }
        
        .timeline-content h4 {
            color: #2d3748;
            margin-bottom: 8px;
        }
        
        .timeline-content p {
            font-size: 14px;
            color: #4a5568;
            line-height: 1.6;
            margin-bottom: 6px;
        }
        
        .lab-table {
            width: 100%;
            border-collapse: collapse;
            margin-top: 15px;
        }
        
        .lab-table th {
            background: #4a5568;
            color: white;
            padding: 12px;
            text-align: left;
            font-weight: 600;
        }
        
        .lab-table td {
            padding: 10px 12px;
            border-bottom: 1px solid #e2e8f0;
        }
        
        .lab-table tr:hover {
            background: #f7fafc;
        }
        
        .lab-table td strong {
            font-weight: 700;
            color: #2d3748;
        }
        
        .status-badge {
            display: inline-block;
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 12px;
            font-weight: 600;
        }
        
        .status-normal {
            background: #c6f6d5;
            color: #22543d;
        }
        
        .status-abnormal {
            background: #fed7d7;
            color: #742a2a;
        }
        
        .status-expected {
            background: #bee3f8;
            color: #2c5282;
        }
        
        .followup-list {
            background: #f7fafc;
            padding: 20px;
            border-radius: 8px;
            border: 1px solid #e2e8f0;
        }
        
        .followup-list ul {
            list-style: none;
            padding-left: 0;
        }
        
        .followup-list li {
            padding: 8px 0;
            padding-left: 25px;
            position: relative;
            color: #4a5568;
        }
        
        .followup-list li::before {
            content: 'âœ“';
            position: absolute;
            left: 0;
            color: #48bb78;
            font-weight: bold;
        }
        
        .appointment-card {
            background: white;
            border: 1px solid #e2e8f0;
            border-left: 4px solid #4299e1;
            padding: 15px;
            margin-bottom: 10px;
            border-radius: 5px;
        }
        
        .appointment-card h4 {
            color: #2d3748;
            margin-bottom: 5px;
        }
        
        .appointment-card p {
            font-size: 14px;
            color: #718096;
        }
        
        .footer {
            background: #2d3748;
            color: white;
            text-align: center;
            padding: 20px;
            font-size: 12px;
        }
        
        @media print {
            body {
                background: white;
                padding: 0;
            }
            .container {
                box-shadow: none;
            }
        }
    </style>
</head>
<body>
<div class="container">
<div class="header">
<h1>PATIENT MEDICAL SUMMARY</h1>
<p>Metropolitan Cancer Center | Electronic Health Record</p>
<p>Generated: November 15, 2024 | Report ID: EHR-2024-11-789456</p>
</div>
<div class="patient-info">
<div class="info-card">
<h3>Patient Name</h3>
<p>DOE, JOHN</p>
</div>
<div class="info-card">
<h3>Medical Record Number</h3>
<p>MRN-2024-789456</p>
</div>
<div class="info-card">
<h3>Date of Birth</h3>
<p>03/15/1965 (59 years)</p>
</div>
<div class="info-card">
<h3>Sex</h3>
<p>Male</p>
</div>
<div class="info-card">
<h3>Primary Physician</h3>
<p>Dr. Sarah Mitchell, MD</p>
</div>
<div class="info-card">
<h3>Last Visit</h3>
<p>11/15/2024</p>
</div>
</div>
<div class="content">
<!-- Active Diagnoses -->
<div class="section" id="hyperlipidemia">
<h2>ðŸ”´ Active &amp; Chronic Diagnoses</h2>
<div class="diagnosis-list">
<div class="diagnosis-item">
<nav><a href="#prostatic-adenocarcinoma">Prostatic Adenocarcinoma (Active)</a></nav>
<p><strong>Stage:</strong> cT2b N0 M0 (Stage II)</p>
<p><strong>Grade:</strong> Gleason 4+3=7 (Grade Group 3)</p>
<p><strong>Diagnosed:</strong> February 2024</p>
<p><strong>Risk Category:</strong> Unfavorable intermediate-risk</p>
<p><strong>Status:</strong> Active treatment - EBRT + ADT ongoing</p>
<p><strong>PSA at diagnosis:</strong> 13.5 ng/mL</p>
</div>
<div class="diagnosis-item chronic">
<nav><a href="#essential-hypertension">Essential Hypertension (Chronic)</a></nav>
<p><strong>Diagnosed:</strong> 2018</p>
<p><strong>Status:</strong> Well-controlled on medication</p>
</div>
<div class="diagnosis-item chronic">
<nav><a href="#hyperlipidemia">Hyperlipidemia (Chronic)</a></nav>
<p><strong>Diagnosed:</strong> 2019</p>
<p><strong>Status:</strong> Well-controlled on statin therapy</p>
</div>
<div class="diagnosis-item chronic">
<nav><a href="#benign-prostatic-hyperplasia">Benign Prostatic Hyperplasia (Chronic)</a></nav>
<p><strong>Diagnosed:</strong> 2020</p>
<p><strong>Status:</strong> Managed medically, symptoms improved</p>
</div>
</div>
</div>
<!-- Treatment Timeline -->
<div class="section">
<h2>ðŸ“… Treatment Timeline</h2>
<div class="timeline">
<div class="timeline-item">
<div class="timeline-date">January 15, 2024</div>
<div class="timeline-content">
<h4>Initial Consultation</h4>
<p><strong>Details:</strong> Patient presented with elevated PSA (13.5 ng/mL) and abnormal DRE. Family history negative for prostate cancer.</p>
<p><strong>Outcome:</strong> Referred for prostate MRI and biopsy</p>
</div>
</div>
<div class="timeline-item">
<div class="timeline-date">January 28, 2024</div>
<div class="timeline-content">
<h4>Multiparametric Prostate MRI</h4>
<p><strong>Details:</strong> PI-RADS 4 lesion identified in right mid-gland, measuring 1.3 cm. No extracapsular extension or seminal vesicle invasion.</p>
<p><strong>Outcome:</strong> Recommended MRI-fusion biopsy</p>
</div>
</div>
<div class="timeline-item critical" id="benign-prostatic-hyperplasia">
<div class="timeline-date">February 1, 2024</div>
<div class="timeline-content">
<h4>MRI-Fusion Prostate Biopsy</h4>
<p><strong>Details:</strong> 12-core systematic biopsy + 2 targeted cores. Positive for adenocarcinoma in 4/14 cores (28%). Right mid-gland involvement.</p>
<p><strong>Pathology:</strong> Gleason 4+3=7 (Grade Group 3), 45% core involvement</p>
<p><strong>Outcome:</strong> Diagnosis confirmed - Prostatic adenocarcinoma</p>
</div>
</div>
<div class="timeline-item">
<div class="timeline-date">February 15, 2024</div>
<div class="timeline-content">
<h4>Staging Workup Completed</h4>
<p><strong>Details:</strong> Bone scan: negative for metastases. CT abdomen/pelvis: no lymphadenopathy. Clinical stage: cT2b N0 M0.</p>
<p><strong>Outcome:</strong> Unfavorable intermediate-risk prostate cancer confirmed</p>
</div>
</div>
<div class="timeline-item">
<div class="timeline-date">March 1, 2024</div>
<div class="timeline-content">
<h4>Treatment Planning Consultation</h4>
<p><strong>Details:</strong> Discussed treatment options: radical prostatectomy vs. radiation therapy + ADT. Patient elected for radiation therapy.</p>
<p><strong>Outcome:</strong> Plan: EBRT 78 Gy in 39 fractions + 6 months ADT</p>
</div>
</div>
<div class="timeline-item critical">
<div class="timeline-date">March 15, 2024</div>
<div class="timeline-content">
<h4>Androgen Deprivation Therapy Initiated</h4>
<p><strong>Details:</strong> Leuprolide acetate (Lupron Depot) 22.5 mg IM injection. Baseline testosterone: 425 ng/dL.</p>
<p><strong>Outcome:</strong> Goal: testosterone suppression &lt;50 ng/dL prior to radiation</p>
</div>
</div>
<div class="timeline-item">
<div class="timeline-date">April 10, 2024</div>
<div class="timeline-content">
<h4>CT Simulation for Radiation Planning</h4>
<p><strong>Details:</strong> Fiducial markers placed. Full bladder protocol. CT images acquired for treatment planning.</p>
<p><strong>Outcome:</strong> Radiation plan approved: IMRT/VMAT technique</p>
</div>
</div>
<div class="timeline-item critical">
<div class="timeline-date">April 22, 2024</div>
<div class="timeline-content">
<h4>External Beam Radiation Therapy Started</h4>
<p><strong>Details:</strong> 78 Gy in 39 fractions (2.0 Gy per fraction). Daily IGRT with fiducial-based image guidance.</p>
<p><strong>Outcome:</strong> Treatment ongoing, tolerating well</p>
</div>
</div>
<div class="timeline-item">
<div class="timeline-date">May 20, 2024</div>
<div class="timeline-content">
<h4>Mid-Treatment Assessment</h4>
<p><strong>Details:</strong> Completed 20/39 fractions. Mild urinary frequency (Grade 1). No rectal symptoms.</p>
<p><strong>Outcome:</strong> Continue treatment as planned</p>
</div>
</div>
<div class="timeline-item critical">
<div class="timeline-date">June 28, 2024</div>
<div class="timeline-content">
<h4>Radiation Therapy Completed</h4>
<p><strong>Details:</strong> All 39 fractions delivered. Total dose: 78 Gy. Acute toxicity: Grade 2 urinary frequency/urgency, Grade 1 rectal discomfort.</p>
<p><strong>Outcome:</strong> Excellent treatment completion. PSA expected to nadir over 18-24 months</p>
</div>
</div>
<div class="timeline-item">
<div class="timeline-date">September 15, 2024</div>
<div class="timeline-content">
<h4>Second Lupron Injection</h4>
<p><strong>Details:</strong> Leuprolide 22.5 mg IM (3-month follow-up). Testosterone: 18 ng/dL (adequately suppressed).</p>
<p><strong>Outcome:</strong> Total ADT duration: 6 months (2 more injections planned)</p>
</div>
</div>
<div class="timeline-item">
<div class="timeline-date">November 15, 2024</div>
<div class="timeline-content">
<h4>Current Visit - Post-RT Follow-up</h4>
<p><strong>Details:</strong> PSA: 8.2 ng/mL (expected decline from 13.5). Urinary symptoms resolved. Quality of life good.</p>
<p><strong>Outcome:</strong> Continue ADT, PSA monitoring every 3 months</p>
</div>
</div>
</div>
</div>
<!-- Recent Labs -->
<div class="section">
<h2>ðŸ”¬ Most Recent Laboratory Results (11/15/2024)</h2>
<table class="lab-table">
<thead>
<tr>
<th>Test</th>
<th>Result</th>
<th>Units</th>
<th>Reference Range</th>
<th>Status</th>
</tr>
</thead>
<tbody>
<tr>
<td>PSA</td>
<td><strong>8.2</strong></td>
<td>ng/mL</td>
<td>0-4.0</td>
<td><span class="status-badge status-expected">Declining (expected)</span></td>
</tr>
<tr>
<td>Testosterone</td>
<td><strong>18</strong></td>
<td>ng/dL</td>
<td>300-1000</td>
<td><span class="status-badge status-expected">Suppressed (goal)</span></td>
</tr>
<tr>
<td>Hemoglobin</td>
<td><strong>12.9</strong></td>
<td>g/dL</td>
<td>13.5-17.5</td>
<td><span class="status-badge status-abnormal">Mild anemia</span></td>
</tr>
<tr>
<td>WBC</td>
<td><strong>6.8</strong></td>
<td>K/uL</td>
<td>4.5-11.0</td>
<td><span class="status-badge status-normal">Normal</span></td>
</tr>
<tr>
<td>Platelet</td>
<td><strong>245</strong></td>
<td>K/uL</td>
<td>150-400</td>
<td><span class="status-badge status-normal">Normal</span></td>
</tr>
<tr>
<td>Creatinine</td>
<td><strong>1.2</strong></td>
<td>mg/dL</td>
<td>0.7-1.3</td>
<td><span class="status-badge status-normal">Normal</span></td>
</tr>
<tr>
<td>ALT</td>
<td><strong>28</strong></td>
<td>U/L</td>
<td>7-56</td>
<td><span class="status-badge status-normal">Normal</span></td>
</tr>
<tr>
<td>Alkaline Phosphatase</td>
<td><strong>72</strong></td>
<td>U/L</td>
<td>40-150</td>
<td><span class="status-badge status-normal">Normal</span></td>
</tr>
</tbody>
</table>
</div>
<!-- Current Medications -->
<div class="section">
<h2>ðŸ’Š Current Medications</h2>
<table class="lab-table">
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
<th>Frequency</th>
<th>Indication</th>
<th>Status</th>
</tr>
</thead>
<tbody>
<tr>
<td>Leuprolide acetate (Lupron Depot)</td>
<td>22.5 mg IM</td>
<td>Every 3 months</td>
<td>Androgen deprivation therapy</td>
<td><span class="status-badge status-normal">Active</span></td>
</tr>
<tr>
<td>Tamsulosin (Flomax)</td>
<td>0.4 mg PO</td>
<td>Daily at bedtime</td>
<td>Urinary symptoms (BPH/post-RT)</td>
<td><span class="status-badge status-normal">Active</span></td>
</tr>
<tr>
<td>Lisinopril</td>
<td>10 mg PO</td>
<td>Daily</td>
<td>Hypertension</td>
<td><span class="status-badge status-normal">Active</span></td>
</tr>
<tr>
<td>Atorvastatin (Lipitor)</td>
<td>20 mg PO</td>
<td>Daily</td>
<td>Hyperlipidemia</td>
<td><span class="status-badge status-normal">Active</span></td>
</tr>
<tr>
<td>Aspirin</td>
<td>81 mg PO</td>
<td>Daily</td>
<td>Cardiovascular prophylaxis</td>
<td><span class="status-badge status-normal">Active</span></td>
</tr>
<tr>
<td>Vitamin D3</td>
<td>2000 IU PO</td>
<td>Daily</td>
<td>Bone health (ADT)</td>
<td><span class="status-badge status-normal">Active</span></td>
</tr>
<tr>
<td>Calcium carbonate</td>
<td>500 mg PO</td>
<td>Twice daily</td>
<td>Bone health (ADT)</td>
<td><span class="status-badge status-normal">Active</span></td>
</tr>
</tbody>
</table>
</div>
<!-- Follow-up Plan -->
<div class="section">
<h2>ðŸ“‹ Follow-up Plan</h2>
<h3 style="color: #2d3748; margin-top: 20px; margin-bottom: 15px;">Prostate Cancer Surveillance</h3>
<div class="followup-list">
<ul>
<li>PSA every 3 months for first 2 years</li>
<li>Then PSA every 6 months for years 3-5</li>
<li>Then PSA annually after 5 years</li>
<li>Monitor for biochemical recurrence (PSA nadir + 2 ng/mL)</li>
<li>Assess for late GU/GI toxicity at each visit</li>
<li>DEXA scan for bone density (ADT effect) - schedule for January 2025</li>
</ul>
</div>
<h3 style="color: #2d3748; margin-top: 25px; margin-bottom: 15px;">Next Scheduled Appointments</h3>
<div class="appointment-card">
<h4>Radiation Oncology - February 15, 2025</h4>
<p><strong>Provider:</strong> Dr. Sarah Mitchell, MD</p>
<p><strong>Purpose:</strong> PSA check, toxicity assessment</p>
</div>
<div class="appointment-card">
<h4>Medical Oncology - December 15, 2024</h4>
<p><strong>Provider:</strong> Dr. James Rodriguez, MD</p>
<p><strong>Purpose:</strong> Third Lupron injection</p>
</div>
<div class="appointment-card">
<h4>Primary Care - January 20, 2025</h4>
<p><strong>Provider:</strong> Dr. Emily Chen, MD</p>
<p><strong>Purpose:</strong> Annual physical, comorbidity management</p>
</div>
</div>
</div>
<div class="footer">
<p>Metropolitan Cancer Center | Department of Radiation Oncology</p>
<p>This document contains protected health information (PHI) and is confidential.</p>
<p>Generated: 11/15/2024 14:35 | Report ID: EHR-2024-11-789456</p>
</div>
</div>
</body>
</html>
